Racial Disparity in Gastrointestinal Cancer Risk

Gastroenterology

Volumn 153, Issue 4, 2017, Pages 910-923

  Ashktorab, Hassan ^a,b   Kupfer, Sonia S ^c   Brim, Hassan ^d   Carethers, John M ^e  

^a HOWARD UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b HOWARD UNIVERSITY CANCER CENTER   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

^d HOWARD UNIVERSITY   (United States)

^e UNIVERSITY OF MICHIGAN COMPREHENSIVE CANCER CENTER   (United States)

Author keywords

African American; Anal Cancer; Cancer Disparity; Cancer Epidemiology; Cancer Risk; Colorectal Cancer; Esophageal Cancer; Gastric Cancer; Hepatocellular Carcinoma; Pancreatic Cancer; Racial Disparity; Small Bowel Cancer

Indexed keywords

CANCER VACCINE;

ANUS CANCER; CANCER DIAGNOSIS; CANCER IMMUNIZATION; CANCER INCIDENCE; CANCER MORTALITY; CANCER PREVENTION; CANCER RISK; CANCER THERAPY; COLORECTAL CANCER; DIGESTIVE SYSTEM CANCER; DISEASE ASSOCIATION; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; GASTROENTEROLOGY; HEALTH CARE ACCESS; HEALTH CARE DISPARITY; HEPATITIS B; HEPATITIS C; HUMAN; LIVER CANCER; LIVER CIRRHOSIS; NONALCOHOLIC FATTY LIVER; PANCREAS CANCER; PERSONALIZED MEDICINE; PRIORITY JOURNAL; RACE DIFFERENCE; REVIEW; SMALL INTESTINE CANCER; SOCIOECONOMICS; STOMACH CANCER; VERTICAL TRANSMISSION; ANCESTRY GROUP; DIGESTIVE SYSTEM NEOPLASMS; EPIDEMIOLOGY; ETHNOLOGY; FEMALE; HEALTH DISPARITY; INCIDENCE; LIFESTYLE; MALE; MORTALITY; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR; SEX RATIO; TIME FACTOR; UNITED STATES;

CONTINENTAL POPULATION GROUPS; DIGESTIVE SYSTEM NEOPLASMS; FEMALE; HEALTH STATUS DISPARITIES; HUMANS; INCIDENCE; LIFE STYLE; MALE; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; SEX DISTRIBUTION; TIME FACTORS; UNITED STATES;

EID: 85031662956     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2017.08.018     Document Type: Review

References (129)

1. Kamineni, A., Williams, M.A., Schwartz, S.M., et al. The incidence of gastric carcinoma in Asian migrants to the United States and their descendants. Cancer Causes Control 10 (1999), 77–83.
2. O'Keefe, S.J., Chung, D., Mahmoud, N., et al. Why do African Americans get more colon cancer than Native Africans?. J Nutr 137 (2007), 175S–182S.
3. Satia, J.A., Keku, T., Galanko, J.A., et al. Diet, lifestyle, and genomic instability in the North Carolina Colon Cancer Study. Cancer Epidemiol Biomarkers Prev 14 (2005), 429–436.
4. Carethers, J.M., Screening for colorectal cancer in African Americans: determinants and rationale for an earlier age to commence screening. Dig Dis Sci 60 (2015), 711–721.
5. O'Keefe, S.J., Li, J.V., Lahti, L., et al. Fat, fibre and cancer risk in African Americans and rural Africans. Nat Commun, 6, 2015, 6342.
6. Nguyen, T., Ramsey, D., Graham, D., et al. The prevalence of Helicobacter pylori remains high in African American and Hispanic Veterans. Helicobacter 20 (2015), 305–315.
7. Phelan, J.C., Link, B.G., Tehranifar, P., Social conditions as fundamental causes of health inequalities: theory, evidence, and policy implications. J Health Soc Behav 51:Suppl (2010), S28–S40.
8. Siegel, R.L., Miller, K.D., Jemal, A., Cancer statistics, 2017. CA Cancer J Clin 67 (2017), 7–30.
9. Centers for Disease Control and Prevention. CDC Health Disparities and Inequalities Report—United States, 2013. https://www.cdc.gov/mmwr/preview/ind2013_su.html#HealthDisparities2013. Accessed June 1, 2017.
10. Ohashi, S., Miyamoto, S., Kikuchi, O., et al. Recent advances from basic and clinical studies of esophageal squamous cell carcinoma. Gastroenterology 149 (2015), 1700–1715.
11. Rubenstein, J.H., Shaheen, N.J., Epidemiology, diagnosis, and management of esophageal adenocarcinoma. Gastroenterology 149 (2015), 302–317 e1.
12. National Cancer Institute, Surveillance, Epidemiology, and End Results (SEER) Program. Seer.cancer.gov Accessed June 2017.
13. Ashktorab, H., Nouri, Z., Nouraie, M., et al. Esophageal carcinoma in African Americans: a five-decade experience. Dig Dis Sci 56 (2011), 3577–3582.
14. Baquet, C.R., Commiskey, P., Mack, K., et al. Esophageal cancer epidemiology in blacks and whites: racial and gender disparities in incidence, mortality, survival rates and histology. J Natl Med Assoc 97 (2005), 1471–1478.
15. Prabhu, A., Obi, K.O., Rubenstein, J.H., Systematic review with meta-analysis: race-specific effects of alcohol and tobacco on the risk of oesophageal squamous cell carcinoma. Aliment Pharmacol Ther 38 (2013), 1145–1155.
16. Brown, L.M., Hoover, R.N., Greenberg, R.S., et al. Are racial differences in squamous cell esophageal cancer explained by alcohol and tobacco use?. J Natl Cancer Inst 86 (1994), 1340–1345.
17. Prabhu, A., Obi, K., Lieberman, D., et al. The race-specific incidence of esophageal squamous cell carcinoma in individuals with exposure to tobacco and alcohol. Am J Gastroenterol 111 (2016), 1718–1725.
18. Cui, R., Kamatani, Y., Takahashi, A., et al. Functional variants in ADH1B and ALDH2 coupled with alcohol and smoking synergistically enhance esophageal cancer risk. Gastroenterology 137 (2009), 1768–1775.
19. 1000 Genomes Project Consortium, Auton, A., Brooks, L.D., Durbin, R.M., et al. A global reference for human genetic variation. Nature 526 (2015), 68–74.
20. Abnet, C.C., Freedman, N.D., Hu, N., et al. A shared susceptibility locus in PLCE1 at 10q23 for gastric adenocarcinoma and esophageal squamous cell carcinoma. Nat Genet 42 (2010), 764–767.
21. Wang, L.D., Zhou, F.Y., Li, X.M., et al. Genome-wide association study of esophageal squamous cell carcinoma in Chinese subjects identifies susceptibility loci at PLCE1 and C20orf54. Nat Genet 4 (2010), 759–763.
22. American Gastroenterological Association, Spechler, S.J., Sharma, P., Souza, R.F., et al. American Gastroenterological Association medical position statement on the management of Barrett's esophagus. Gastroenterology 140 (2011), 1084–1091.
23. El-Serag, H.B., Petersen, N.J., Carter, J., et al. Gastroesophageal reflux among different racial groups in the United States. Gastroenterology 126 (2004), 1692–1699.
24. Corley, D.A., Kubo, A., Levin, T.R., et al. Race, ethnicity, sex and temporal differences in Barrett's oesophagus diagnosis: a large community-based study, 1994-2006. Gut 58 (2009), 182–188.
25. Dong, E., Duan, L., Wu, B.U., Racial and ethnic minorities at increased risk for gastric cancer in a regional US population study. Clin Gastroenterol Hepatol 15 (2017), 511–517.
26. Palles, C., Chegwidden, L., Li, X., et al. Polymorphisms near TBX5 and GDF7 are associated with increased risk for Barrett's esophagus. Gastroenterology 148 (2015), 367–378.
27. Su, Z., Gay, L.J., Strange, A., et al., Esophageal Adenocarcinoma Genetics Consortium; Wellcome Trust Case Control Consortium 2. Common variants at the MHC locus and at chromosome 16q24.1 predispose to Barrett's esophagus. Nat Genet 44 (2012), 1131–1136.
28. Dai, J.Y., de Dieu Tapsoba, J., Buas, M.F., et al. A newly identified susceptibility locus near FOXP1 modifies the association of gastroesophageal reflux with Barrett's esophagus. Cancer Epidemiol Biomarkers Prev 24 (2015), 1739–1747.
29. Levine, D.M., Ek, W.E., Zhang, R., et al. A genome-wide association study identifies new susceptibility loci for esophageal adenocarcinoma and Barrett's esophagus. Nat Genet 45 (2013), 1487–1493.
30. Karimi, P., Islami, F., Anandasabapathy, S., et al. Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention. Cancer Epidemiol Biomarkers Prev 23 (2014), 700–713.
31. de Martel, C., Forman, D., Plummer, M., Gastric cancer: epidemiology and risk factors. Gastroenterol Clin North Am 42 (2013), 219–240.
32. Kim, H.W., Kim, J.H., Lim, B.J., et al. Sex disparity in gastric cancer: female sex is a poor prognostic factor for advanced gastric cancer. Ann Surg Oncol 23 (2016), 4344–4351.
33. Ford, A.C., Forman, D., Hunt, R., et al. Helicobacter pylori eradication for the prevention of gastric neoplasia. Cochrane Database Syst Rev, 2015, CD005583.
34. Helgason, H., Rafnar, T., Olafsdottir, H.S., et al. Loss-of-function variants in ATM confer risk of gastric cancer. Nat Genet 47 (2015), 906–910.
35. Saeki, N., Saito, A., Choi, I.J., et al. A functional single nucleotide polymorphism in mucin 1, at chromosome 1q22, determines susceptibility to diffuse-type gastric cancer. Gastroenterology 140 (2011), 892–902.
36. Sun, H., Wu, X., Wu, F., et al. Associations of genetic variants in the PSCA, MUC1 and PLCE1 genes with stomach cancer susceptibility in a Chinese population. PLoS One, 10, 2015, e0117576.
37. Miyazaki, T., Murayama, Y., Shinomura, Y., et al. E-cadherin gene promoter hypermethylation in H pylori-induced enlarged fold gastritis. Helicobacter 12 (2007), 523–531.
38. Khawja, S.N., Mohammed, S., Silberfein, E.J., et al. Pancreatic cancer disparities in African Americans. Pancreas 44 (2015), 522–527.
39. Chang, K.J., Parasher, G., Christie, C., et al. Risk of pancreatic adenocarcinoma: disparity between African Americans and other race/ethnic groups. Cancer 103 (2005), 349–357.
40. Klein, A.P., Brune, K.A., Petersen, G.M., et al. Prospective risk of pancreatic cancer in familial pancreatic cancer kindreds. Cancer Res 64 (2004), 2634–2638.
41. Syngal, S., Brand, R.E., Church, J.M., et al., American College of Gastroenterology. ACG clinical guideline: genetic testing and management of hereditary gastrointestinal cancer syndromes. Am J Gastroenterol 110 (2015), 223–262.
42. Amundadottir, L.T., Pancreatic cancer genetics. Int J Biol Sci 12 (2016), 314–325.
43. Zhang, M., Wang, Z., Obazee, O., et al. Three new pancreatic cancer susceptibility signals identified on chromosomes 1q32.1, 5p15.33 and 8q24.21. Oncotarget 7 (2016), 66328–66343.
44. Childs, E.J., Mocci, E., Campa, D., et al. Common variation at 2p13.3, 3q29, 7p13 and 17q25.1 associated with susceptibility to pancreatic cancer. Nat Genet 47 (2015), 911–916.
45. Willis, J.A., Olson, S.H., Orlow, I., et al. A replication study and genome-wide scan of single-nucleotide polymorphisms associated with pancreatic cancer risk and overall survival. Clin Cancer Res 18 (2012), 3942–3951.
46. Hart, A.R., Kennedy, H., Harvey, I., Pancreatic cancer: a review of the evidence on causation. Clin Gastroenterol Hepatol 6 (2008), 275–282.
47. Bethea, T.N., Kitahara, C.M., Sonderman, J., et al. A pooled analysis of body mass index and pancreatic cancer mortality in African Americans. Cancer Epidemiol Biomarkers Prev 23 (2014), 2119–2225.
48. Silverman, D.T., Hoover, R.N., Brown, L.M., et al. Why do black Americans have a higher risk of pancreatic cancer than White Americans?. Epidemiology 14 (2003), 45–54.
49. Arnold, L.D., Patel, A.V., Yan, Y., et al. Are racial disparities in pancreatic cancer explained by smoking and overweight/obesity?. Cancer Epidemiol Biomarkers Prev 18 (2009), 2397–2405.
50. Pourmand, K., Itzkowitz, S.H., Small bowel neoplasms and polyps. Curr Gastroenterol Rep, 18, 2016, 23.
51. Goodman, M.T., Matsuno, R.K., Shvetsov, Y.B., Racial and ethnic variation in the incidence of small-bowel cancer subtypes in the United States, 1995−2008. Dis Colon Rectum 56 (2013), 441–448.
52. Coe, T.M., Fero, K.E., Fanta, P.T., et al. Population-based epidemiology and mortality of small malignant gastrointestinal stromal tumors in the USA. J Gastrointest Surg 20 (2016), 1132–1140.
53. Tran, T., Davila, J.A., El-Serag, H.B., The epidemiology of malignant gastrointestinal stromal tumors: an analysis of 1,458 cases from 1992 to 2000. Am J Gastroenterol 100 (2005), 162–168.
54. Shenoy, S., Genetic risks and familial associations of small bowel carcinoma. World J Gastrointest Oncol 8 (2016), 509–519.
55. Rubio-Tapia, A., Ludvigsson, J.F., Brantner, T.L., et al. The prevalence of celiac disease in the United States. Am J Gastroenterol 107 (2012), 1538–1544.
56. Choung, R.S., Ditah, I.C., Nadeau, A.M., et al. Trends and racial/ethnic disparities in gluten-sensitive problems in the United States: findings from the National Health and Nutrition Examination Surveys from 1988 to 2012. Am J Gastroenterol 110 (2015), 455–461.
57. Du, Y., Ter-Minassian, M., Brais, L., et al. Genetic associations with neuroendocrine tumor risk: results from a genome-wide association study. Endocr Relat Cancer 23 (2016), 587–594.
58. Leoncini, E., Carioli, G., La Vecchia, C., et al. Risk factors for neuroendocrine neoplasms: a systematic review and meta-analysis. Ann Oncol 27 (2016), 68–81.
59. Grady, W.M., Carethers, J.M., Genomic and epigenetic instability in colorectal cancer pathogenesis. Gastroenterology 135 (2008), 1079–1099.
60. Carethers, J.M., Jung, B.H., Genetics and genetic biomarkers in sporadic colorectal cancer. Gastroenterology 149 (2015), 1177–1190.
61. Carethers, J.M., Stoffel, E.M., Lynch syndrome and Lynch syndrome mimics: the growing complex landscape of hereditary colon cancer. World J Gastroenterol 21 (2015), 9253–9261.
62. Guindalini, R.S., Win, A.K., Gulden, C., et al. Mutation spectrum and risk of colorectal cancer in African American families with Lynch syndrome. Gastroenterology 149 (2015), 1446–1453.
63. Levin, B., Lieberman, D.A., McFarland, B., et al., American Cancer Society Colorectal Cancer Advisory Group.; US Multi-Society Task Force; American College of Radiology Colon Cancer Committee. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology 134 (2008), 1570–1595.
64. Rex, D.K., Boland, C.R., Dominitz, J.A., et al. Colorectal cancer screening: recommendations for physicians and patients from the United States Multi-Society Task Force on Colorectal Cancer. Gastroenterology 153 (2017), 307–323.
65. Carethers, J.M., Should African Americans be screened for colorectal cancer earlier?. Nat Clin Pract Gastroenterol Hepatol 2 (2005), 352–353.
66. Naylor, K., Ward, J., Polite, B.N., Interventions to improve care related to colorectal cancer among racial and ethnic minorities: a systematic review. J Gen Intern Med 27 (2012), 1033–1046.
67. Ayanian, J.Z., Carethers, J.M., Bridging behavior and biology to reduce socioeconomic disparities in colorectal cancer risk. J Natl Cancer Inst 104 (2012), 1343–1344.
68. Grubbs, S.S., Polite, B.N., Carney, J. Jr., et al. Eliminating racial disparities in colorectal cancer in the real world: it took a village. J Clin Oncol 31 (2013), 1928–1930.
69. Richards, C.A., Kerker, B.D., Thorpe, L., et al. Increased screening colonoscopy rates and reduced racial disparities in the New York Citywide campaign: an urban model. Am J Gastroenterol 106 (2011), 1880–1886.
70. Amri, R., Bordeianou, L.G., Berger, D.L., The conundrum of the young colon cancer patient. Surgery 158 (2015), 1696–1703.
71. Ashktorab, H., Vilmenay, K., Brim, H., et al. Colorectal cancer in young African Americans: is it time to revisit guidelines and prevention?. Dig Dis Sci 61 (2016), 3026–3030.
72. Carethers, J.M., The increasing incidence of colorectal cancers diagnosed in subjects under age 50 among races: cracking the conundrum. Dig Dis Sci 61 (2016), 2767–2769.
73. DeSantis, C.E., Siegel, R.L., Sauer, A.G., et al. Cancer statistics for African Americans, 2016: progress and opportunities in reducing racial disparities. CA Cancer J Clin 66 (2016), 290–308.
74. Carethers, J.M., Racial and ethnic factors in the genetic pathogenesis of colorectal cancer. J Assoc Acad Minor Phys 10 (1999), 59–67.
75. Agrawal, S., Bhupinderjit, A., Bhutani, M.S., et al., Committee of Minority Affairs and Cultural Diversity, American College of Gastroenterology. Colorectal cancer in African Americans. Am J Gastroenterol 100 (2005), 515–523.
76. Tammana, V.S., Laiyemo, A.O., Colorectal cancer disparities: issues, controversies and solutions. World J Gastroenterol 20 (2014), 869–876.
77. Laiyemo, A.O., Doubeni, C., Pinsky, P.F., et al. Race and colorectal cancer disparities: health-care utilization vs different cancer susceptibilities. J Natl Cancer Inst 102 (2010), 538–546.
78. Shields, H.M., Stoffel, E.M., Chung, D.C., et al. Disparities in evaluation of patients with rectal bleeding 40 years and older. Clin Gastroenterol Hepatol 12 (2014), 669–675.
79. Chen, L.A., Santos, S., Jandorf, L., et al. A program to enhance completion of screening colonoscopy among urban minorities. Clin Gastroenterol Hepatol 6 (2008), 443–450.
80. Jandorf, L., Cooperman, J.L., Stossel, L.M., et al. Implementation of culturally targeted patient navigation system for screening colonoscopy in a direct referral system. Health Educ Res 28 (2013), 803–815.
81. + T cell infiltration in colon cancer. PLoS One, 9, 2014, e100461.
82. Lieberman, D.A., Williams, J.L., Holub, J.L., et al. Race, ethnicity, and sex affect risk for polyps >9 mm in average-risk individuals. Gastroenterology 147 (2014), 351–358.
83. Corley, D.A., Jensen, C.D., Marks, A.R., et al. Variation of adenoma prevalence by age, sex, race, and colon location in a large population: implications for screening and quality programs. Clin Gastroenterol Hepatol 11 (2013), 172–180.
84. Brenner, H., Chang-Claude, J., Seiler, C.M., et al. Protection from colorectal cancer after colonoscopy: a population-based, case-control study. Ann Intern Med 154 (2011), 22–30.
85. Nishihara, R., Wu, K., Lochhead, P., Morikawa, T., et al. Long-term colorectal-cancer incidence and mortality after lower endoscopy. N Engl J Med 369 (2013), 1095–1105.
86. Xicola, R.M., Gagnon, M., Clark, J.R., et al. Excess of proximal microsatellite-stable colorectal cancer in African Americans from a multiethnic study. Clin Cancer Res 20 (2014), 4962–4970.
87. Yoon, H.H., Shi, Q., Alberts, S.R., et al., Alliance for Clinical Trials in Oncology. Racial differences in BRAF/KRAS mutation rates and survival in stage III colon cancer patients. J Natl Cancer Inst, 107(10), 2015.
88. Guda, K., Veigl, M.L., Varadan, V., et al. Novel recurrently mutated genes in African American colon cancers. Proc Natl Acad Sci U S A 112 (2015), 1149–1154.
89. Ashktorab, H., Daremipouran, M., Devaney, J., et al. Identification of novel mutations by exome sequencing in African American colorectal cancer patients. Cancer 121 (2015), 34–42.
90. Ashktorab, H., Ahuja, S., Kannan, L., et al. A meta-analysis of MSI frequency and race in colorectal cancer. Oncotarget 7 (2016), 34546–34557.
91. Carethers, J.M., Koi, M., Tseng-Rogenski, S.S., EMAST is a form of microsatellite instability that is initiated by inflammation and modulates colorectal cancer progression. Genes (Basel) 6 (2015), 185–205.
92. Devaraj, B., Lee, A., Cabrera, B.L., et al. Relationship of EMAST and microsatellite instability among patients with rectal cancer. J Gastrointest Surg 14 (2010), 1521–1528.
93. Ashktorab, H., Daremipouran, M., Goel, A., et al. DNA methylome profiling identifies novel methylated genes in African American patients with colorectal neoplasia. Epigenetics 9 (2014), 503–512.
94. Ashktorab, J., Wansley, D., Rahi, J., et al. Toward a comprehensive and systemic methylome signature in colorectal cancers. Epigenetics 8 (2013), 807–815.
95. Lemire, M., Qu, C., Loo, L.W., et al. A genome-wide association study for colorectal cancer identifies a risk locus in 14q23.1. Hum Genet 134 (2015), 1249–1262.
96. Wang, H., Burnett, T., Kono, S., et al. Genetics and Epidemiology of Colorectal Cancer Consortium (GECCO), Colon Cancer Family Registry (CCFR); Colorectal Transdisciplinary Study (CORECT). Trans-ethnic genome-wide association study of colorectal cancer identifies a new susceptibility locus in VTI1A. Nat Commun, 5, 2014, 4613.
97. Kupfer, S.S., Anderson, J.R., Hooker, S., et al. Genetic heterogeneity in colorectal cancer associations between African and European Americans. Gastroenterology 139 (2010), 1677–1685 1685.e1−e8.
98. Kupfer, S.S., Skol, A.D., Hong, E., et al. Shared and independent colorectal cancer risk alleles in TGFβ-related genes in African and European Americans. Carcinogenesis 35 (2014), 2025–2030.
99. Basa, R.C.B., Davies, V., Li, X., Murali, B., Shah, J., Yang, B., et al. Decreased anti-tumor cytotoxic immunity among colon cancers from African Americans. PLoS One, 11, 2016, e0156660.
100. Carethers, J.M., Hereditary, sporadic and metastatic colorectal cancers are commonly driven by specific spectrums of defective DNA mismatch repair components. Trans Am Clin Climatol Assoc 127 (2016), 81–97.
101. Le, D.T., Uram, J.N., Wang, H., et al. PD-1 Blockade in tumors with mismatch-repair deficiency. N Engl J Med 372 (2015), 2509–2520.
102. Koi, M., Carethers, J.M., The colorectal cancer immune microenvironment and approach to immunotherapies. Future Oncol, 2017 Aug 22 http://dx.doi.org/10.2217/fon-2017-0145 [Epub ahead of print].
103. Kaminski, M.F., Wieszczy, P., Rupinski, M., et al. Increased rate of adenoma detection associates with reduced risk of colorectal cancer and death. Gastroenterology 153 (2017), 98–105.
104. Fedewa, S.A., Flanders, W.D., Ward, K.C., et al. Racial and ethnic disparities in interval colorectal cancer incidence: a population-based cohort study. Ann Intern Med 166 (2017), 857–866.
105. Kupfer, S.S., Carr, R.M., Carethers, J.M., Reducing colorectal cancer risk among African Americans. Gastroenterology 149 (2015), 1302–1304.
106. Knudsen, A.B., Zauber, A.G., Rutter, C.M., et al. Estimation of benefits, burden, and harms of colorectal cancer screening strategies: modeling study for the US Preventive Services Task Force. JAMA 315 (2016), 2595–2609.
107. El-Serag, H.B., Hepatocellular carcinoma. N Engl J Med 365 (2011), 1118–1127.
108. Reddy, K.R., Lim, J.K., Kuo, A., et al., HCV-TARGET Study Group. All-oral direct-acting antiviral therapy in HCV-advanced liver disease is effective in real-world practice: observations through HCV-TARGET database. Aliment Pharmacol Ther 45 (2017), 115–126.
109. Terrault, N.A., Zeuzem, S., Di Bisceglie, A.M., et al., HCV-TARGET Study Group. Effectiveness of ledipasvir-sofosbuvir combination in patients with hepatitis C virus infection and factors associated with sustained virologic response. Gastroenterology 151 (2016), 1131–1140 e5.
110. Sherif, Z.A., Saeed, A., Ghavimi, S., et al. Global epidemiology of nonalcoholic fatty liver disease and perspectives on US minority populations. Dig Dis Sci 61 (2016), 1214–1225.
111. Kalia, H.S., Gaglio, P.J., The prevalence and pathobiology of nonalcoholic fatty liver disease in patients of different races or ethnicities. Clin Liver Dis 20 (2016), 215–224.
112. Palmer, N.D., Musani, S.K., Yerges-Armstrong, L.M., Feitosa, M.F., Bielaket, L.F., et al. Characterization of European ancestry nonalcoholic fatty liver disease-associated variants in individuals of African and Hispanic descent. Hepatology 58 (2013), 966–975.
113. Singal, A.G., El-Serag, H.B., Hepatocellular carcinoma from epidemiology to prevention: translating knowledge into practice. Clin Gastroenterol Hepatol 13 (2015), 2140–2151.
114. Soeberg, M.J., Rogers, K., Currow, D.C., et al. Trends in incidence and survival for anal cancer in New South Wales, Australia, 1972−2009. Cancer Epidemiol 39 (2015), 842–847.
115. van der Zee, R.P., Richel, O., de Vries, H.J., et al. The increasing incidence of anal cancer: can it be explained by trends in risk groups?. Neth J Med 71 (2013), 401–411.
116. Nielsen, A., Munk, C., Kjaer, S.K., Trends in incidence of anal cancer and high-grade anal intraepithelial neoplasia in Denmark, 1978−2008. Int J Cancer 130 (2012), 1168–1173.
117. D'Souza, G., Wentz, A., Wiley, D., et al. Anal cancer screening in men who have sex with men in the multicenter AIDS Cohort Study. J Acquir Immune Defic Syndr 71 (2016), 570–576.
118. Daling, J.R., Madeleine, M.M., Johnson, L.G., et al. Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer. Cancer 101 (2004), 270–280.
119. Johnson, L.G., Madeleine, M.M., Newcomer, L.M., et al. Anal cancer incidence and survival: the surveillance, epidemiology, and end results experience, 1973−2000. Cancer 101 (2004), 281–288.
120. Serrano, B., de Sanjose, S., Tous, S., et al. Human papillomavirus genotype attribution for HPVs 6, 11, 16, 18, 31, 33, 45, 52 and 58 in female anogenital lesions. Eur J Cancer 51 (2015), 1732–1741.
121. Alemany, L., Saunier, M., Alvarado-Cabrero, I., et al. Human papillomavirus DNA prevalence and type distribution in anal carcinomas worldwide. Int J Cancer 136 (2015), 98–107.
122. Morris, V.K., Rashid, A., Rodriguez-Bigas, M., et al. Clinicopathologic features associated with human papillomavirus/p16 in patients with metastatic squamous cell carcinoma of the anal canal. Oncologist 20 (2015), 1247–1252.
123. Ramamoorthy, S., Luo, L., Luo, E., et al. Tobacco smoking and risk of recurrence for squamous cell cancer of the anus. Cancer Detect Prev 32 (2008), 116–120.
124. Ramamoorthy, S., Liu, Y.-T., Luo, L., et al. Detection of multiple human papillomavirus genotypes in anal carcinoma. Infect Agent Cancer, 5, 2010, 17.
125. Castle, P.E., Gage, J.C., Partridge, E.E., et al. Human papillomavirus genotypes detected in clinician-collected and self-collected specimens from women living in the Mississippi Delta. BMC Infect Dis, 13, 2013, 5.
126. Banister, C.E., Messersmith, A.R., Cai, B., et al. Disparity in the persistence of high-risk human papillomavirus genotypes between African American and European American women of college age. J Infect Dis 211 (2015), 100–108.
127. Mohammed, K.A., Geneus, C.J., Osazuwa-Peters, N., et al. Disparities in provider recommendation of human papillomavirus vaccination for United States adolescents. J Adolesc Health 59 (2016), 592–598.
128. Rahman, M., Hirth, J.M., Berenson, A.B., Adherence to ACIP recommendation for human papillomavirus vaccine among US adolescent girls. J Community Health 42 (2017), 385–389.
129. Polite, B.N., Adams-Campbell, L.L., Brawley, O.W., et al. Charting the future of cancer health disparities research: a position statement from the American Association for Cancer Research, the American Cancer Society, the American Society of Clinical Oncology, and the National Cancer Institute. J Clin Oncology, 2017 Jul 24 JCO2017736546 http://dx.doi.org/10.1200/JCO.2017.73.6546 [Epub ahead of print].